Evidence map›Paper›PMID 31074767›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2020

Short-term Calorie Restriction and 17α-Estradiol Administration Elicit Divergent Effects on Proteostatic Processes and Protein Content in Metabolically Active Tissues.

Benjamin F Miller, Gavin A Pharaoh, Karyn L Hamilton, Fredrick F Peelor, James L Kirkland, Willard M Freeman, Shivani N Mann, Michael Kinter, John C Price, Michael B Stout

Open access · bronzeAbstract read
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Multidimensional Modeling to Maximize Adaptations to eXercise: the MJournal of applied physiology (Bethesda, Md. : 1985) · 2025
    Article
  5. Sex as a major determinant of pro-longevity drug efficacy: a review of two decades of the NIA Interventions Testing Program.The journals of gerontology. Series A, Biological sciences and medical sciences · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. A Genetically Heterogeneous Rat Model with Divergent Mitochondrial Genomes.The journals of gerontology. Series A, Biological sciences and medical sciences · 2023
    Article
  18. Article
  19. Article
  20. Role of Estrogen Receptor α in Aging and Chronic Disease.Advances in geriatric medicine and research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Benjamin F MillerAging and Metabolism Research Program, Oklahoma Medical Research Foundation, Fort Collins.
Gavin A PharaohAging and Metabolism Research Program, Oklahoma Medical Research Foundation, Fort Collins.
Karyn L HamiltonHealth and Exercise Science Department, Colorado State University, Fort Collins.
Fredrick F PeelorAging and Metabolism Research Program, Oklahoma Medical Research Foundation, Fort Collins.
James L KirklandRobert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota.
Willard M FreemanDepartment of Physiology, University of Oklahoma Health Sciences Center, Fort Collins.
Shivani N MannReynolds Oklahoma Center on Aging, University of Oklahoma Health Sciences Center, Provo, Utah.
Michael KinterAging and Metabolism Research Program, Oklahoma Medical Research Foundation, Fort Collins.
John C PriceDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, Utah.
Michael B StoutReynolds Oklahoma Center on Aging, University of Oklahoma Health Sciences Center, Provo, Utah.
University of Oklahoma Health Sciences Center · USOklahoma Medical Research Foundation · USBrigham Young University · USColorado State University · USMayo Clinic in Florida · US

Funding

Proteomics CoreP20GM103447 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI David W Dyer · 2012 to 2026
$60.2M
Targeted DNA Methylation and Mitochondrial Heteroplasmy CoreP30AG050911 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI William Edmund Sonntag · 2015 to 2026
$13.9M
GEROSCIENCE TRAINING PROGRAM IN OKLAHOMAT32AG052363 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Benjamin Francis Miller, William Edmund Sonntag · 2017 to 2026
$3.6M
Translational mechanisms of mitochondrial protein synthesisR01AG042569 · NIA · COLORADO STATE UNIVERSITY · PI HAMILTON, KARYN L, MILLER, BENJAMIN FRANCIS · 2013 to 2017
$1.5M
Mechanisms of metabolic, inflammatory and healthspan enhancement by 17a-estradiolR00AG051661 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI STOUT, MICHAEL B · 2018 to 2020
$746k
Mechanisms of metabolic, inflammatory and healthspan enhancement by 17a-estradiolK99AG051661 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI STOUT, MICHAEL B · 2016 to 2017
$278k
BLRD VA I01 BX005592NIA NIH HHS K99 AG051661NIA NIH HHS P30 AG050911NIA NIH HHS R00 AG051661NIA NIH HHS R01 AG042569NIA NIH HHS T32 AG052363NIGMS NIH HHS P20 GM103447
6 · The paper itself

Abstract

17α-Estradiol (17α-E2) is a "non-feminizing" estrogen that extends life span in male, but not female, mice. We recently reported that 17α-E2 had robust beneficial effects on metabolic and inflammatory parameters in aged male mice. However, it remains unclear if 17α-E2 also delays other "hallmarks" of aging, particularly maintaining proteostasis. Here, we used isotope labeling methods in older mice to examine proteostatic mechanisms. We compared weight-matched mild calorie restricted (CR) and 17α-E2 treated male mice with the hypothesis that 17α-E2 would increase protein synthesis for somatic maintenance. 17α-E2 had no effect on protein synthesis or DNA synthesis in multiple tissues, including white adipose tissue. Conversely, mild short-term CR decreased DNA synthesis and increased the protein to DNA synthesis ratio in multiple tissues. Examination of individual protein synthesis and content did not differentiate treatments, although it provided insight into the regulation of protein content between tissues. Contrary to our hypothesis, we did not see the predicted differences in protein to DNA synthesis following 17α-E2 treatment. However, mild short-term CR elicited differences consistent with both lifelong CR and other treatments that curtail aging processes. These data indicated that despite similar maintenance of body mass, 17α-E2 and CR treatments elicit distinctly different proteostatic outcomes.

Indexed as

Caloric RestrictionAgingAnimalsDNAEstradiolMaleMiceMice, Inbred C57BLProtein BiosynthesisProteinsProteostasisDNAEstradiolProteinsDeuterium oxideMetabolismMouseProtein synthesisProteomics

Identifiers

PMID31074767
PMCPMC7164531
OpenAlexW2979251363

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.